CN3743070

Active
Amendment A1

National Supply arrangement for imported immunoglobulin products

The National Blood Authority has a limited-tender contract with CSL BEHRING (AUSTRALIA) PTY LTD valued at AU$1,874,602,218 for the national supply arrangement for imported immunoglobulin products. The contract runs from December 2020 to December 2027 and has one amendment. The limited tender was exempted under TR 10.3.d.iii due to an absence of competition for technical reasons.

$1.9B
Contract Value

Contract Details

Contract ID
CN3743070
Status
active
Financial Year
FY26
Category
Drugs and Pharmaceutical(UNSPSC: 51000000)

Key Dates

Publish Date
9 June 2026
Signed Date
19 Jan 2021
Start Date
31 Dec 2020
End Date
30 Dec 2027
Duration
7 years, 1 month

Procurement Information

Procurement Method
Limited tender
Exemption Code
TR
Exemption Reason
10.3.d.iii. Supply by particular business: due to an absence of competition for technical reasons.

Contract History

This contract has been amended 1 time. Currently showing amendment A1.

Original Contract
Published 19 Jan 2021 · 31 Dec 2020 to 30 Dec 2027
$806.8M
Amendment A1
Current
Published 9 June 2026 · 31 Dec 2020 to 30 Dec 2027
$1.9B
+$1.1B